Premium
Gene Therapy for Cardiovascular Disorders
Author(s) -
METCALFE BEVERLY L.,
SELLERS KATHLEEN W.,
JENG MICHAEL JINGREN,
HUENTELMAN MATTHEW J.,
KATOVICH MICHAEL J.,
RAIZADA MOHAN K.
Publication year - 2001
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1111/j.1749-6632.2001.tb11358.x
Subject(s) - genetic enhancement , medicine , gene , bioinformatics , intensive care medicine , genetics , biology
A bstract : Incidence of cardiovascular disease has reached epidemic proportions in spite of recent advances in improving the efficacy of pharmacotherapeutics. This has led many to conclude that drug therapy has reached a plateau in its effectiveness. As a result, our efforts have been diverted to explore the use of gene transfer approaches for long‐term control of these pathophysiological conditions. The purpose of this review is to present various approaches that are being undertaken to provide “proof of principle” for gene therapy for cardiovascular diseases. Finally, we will discuss the future of gene therapy and other new technologies that may further advance this field of therapeutics.